Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

20.48
Delayed Data
As of Jul 27
 +0.08 / +0.39%
Today’s Change
16.60
Today|||52-Week Range
21.49
-0.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$858.3M

Company Description

Meridian Bioscience, Inc. is a fully integrated life science company, which engages in the development, manufacture, sale, and distribution of diagnostic test kits, purified reagents, and related products and offers biopharmaceutical enabling technologies. It operates in the Diagnostics and Life Science segments. The Diagnostics segment comprises of manufacturing operations in Cincinnati, Ohio, and the sale and distribution of diagnostic test kits in the US, Europe, Africa and the Middle East. The Life Science operating segment consists of manufacturing operations in Memphis, Tennessee; Saco, Maine; Boca Raton, Florida; London, England; Luckenwalde, Germany; and Sydney, Australia and the sale and distribution of bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells and bioresearch reagents domestically and abroad. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.

Contact Information

Meridian Bioscience, Inc.
3471 River Hills Drive
Cincinnati Ohio 45244
P:(513) 271-3700
Investor Relations:

Employees

Shareholders

Mutual fund holders50.65%
Other institutional43.64%
Individual stakeholders4.25%

Top Executives

John A. KraeutlerChairman, President & Chief Executive Officer
Lawrence J. BaldiniEVP-Operations & Information Systems
Melissa A. LuekeChief Financial Officer, Secretary & EVP
Vecheslav A. ElaginExecutive Vice President-Research & Development
Richard L. EberlyExecutive Vice President